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Abstract 
Background: Corynebacterium glutamicum is generally regarded as a safe microorganism and is used to produce 
many biochemicals, including l-glutamate. 5-Aminolevulinic acid (ALA) is an l-glutamate derived non-protein amino 
acid, and is widely applied in fields such as medicine and agriculture.
Results: The products of the gltX, hemA, and hemL genes participate in the synthesis of ALA from l-glutamate. Their 
annotated C. glutamicum homologs were shown to be functional using heterologous complementation and over-
expression techniques. Coexpression of hemA and hemL in native host led to the accumulation of ALA, suggesting 
the potential of C. glutamicum to produce ALA for research and commercial purposes. To improve ALA production, 
we constructed recombinant C. glutamicum strains expressing hemA and hemL derived from different organisms. 
Transcriptome analysis indicated that the dissolved oxygen level and Fe2+ concentration had major effects on ALA 
synthesis. The downstream pathway of heme biosynthesis was inhibited using small molecules or introducing genetic 
modifications. Small-scale flask cultures of engineered C. glutamicum produced 1.79 g/L of ALA.
Conclusion: Functional characterization of the key enzymes indicated complex regulation of the heme biosynthetic 
pathway in C. glutamicum. Systematic analysis and molecular genetic engineering of C. glutamicum may facilitate its 
development as a system for large-scale synthesis of ALA.
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Background
Corynebacterium glutamicum, which occurs naturally in 
soil, is a Gram-positive, nonpathogenic, biotin auxotroph 
bacterium that is used for large-scale industrial produc-
tion of the flavor enhancer l-glutamate and several other 
amino acids [1]. Recent studies demonstrate the poten-
tial of C. glutamicum to produce a variety of other com-
mercially interesting compounds such as organic acids, 
diamines, and biofuels [2]. Because of its importance to 
industrial biotechnology, C. glutamicum serves as a promi-
nent model organism for studying prokaryotic metabolism 
and its regulation as well as providing a subject for apply-
ing the tools and concepts of synthetic biology [3].
The iron-containing tetrapyrrole heme is a cofactor of 
the protein components of the electron transport chain 
that drives aerobic and anaerobic respiration [4]. Certain 
central metabolic pathways and enzymes require heme 
for activity, although excess heme is toxic because of its 
reactive nature [5]. The mechanism of the biosynthesis 
of heme from its first precursor, 5-aminolevulinic acid 
(ALA), is highly conserved among organisms. However, 
the biosynthesis of ALA is regulated at different levels 
depending on species and may be subject to feedback 
inhibition by heme [6]. The key genes gltX, hemA, and 
hemL, which participate in the synthesis of ALA from 
glutamate, were identified in the genome of C. glutami-
cum using in silico techniques, including sequence align-
ments and the identification of domains shared with 
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those of their functionally verified counterparts (Fig. 1). 
However, the sequences of these C. glutamicum genes 
are only 31.53, 25.32, and 47.05  % identical to those of 
GluRS, HemA, and HemL, respectively, of Escherichia 
coli, and the functions of the former are unknown.
5-Aminolevulinic acid is used for photodynamic ther-
apy (PDT) in gastroenterology, urology, and dermatology 
and is used as well as a photosensitizer in photodynamic 
diagnosis [7]. Moreover, the application of low concen-
trations of ALA for agricultural purposes increases the 
tolerance of plants to low temperatures and high salt 
concentrations and is a biodegradable herbicide and 
insecticide [8]. Because the chemical synthesis of ALA 
is complicated and generates relatively low yields, the 
focus of researchers is on using microbial cell factories to 
synthesize ALA, because such systems are environmen-
tally safe, economical, and sustainable [9]. For example, 
microbes such as Rhodobacter sphaeroides and E. coli 
were engineered to produce ALA [10]. However, most 
of these studies focused on the condensation reaction 
of succinyl-CoA and glycine that is catalyzed by ALA 
synthase (C4 pathway) [11]. The C5 biosynthetic path-
way was recently engineered in E. coli to achieve yields 
of 4.13 g/L using batch fermentation [12]. The synthesis 
of ALA from glucose by the C5 pathway is an impor-
tant advantage over the C4 pathway. The heme pathway 
was further optimized, and its regulatory factors such as 
small RNA ryhB were studied as well [13, 14].
Because l-glutamate is a precursor of ALA, and gluta-
mate-producing C. glutamicum is generally regarded as 
safe, we reasoned that it might serve as an ideal host for 
the production of ALA. For this purpose, we conducted 
heterologous complementation and overexpression 
experiments, and demonstrate here, for the first time to 
our knowledge, the function of the key C. glutamicum 
enzymes involved in heme biosynthesis. Moreover, an 
engineered C. glutamicum strain produced ALA at yields 
of 1.79 g/L.
Results
Functional identification of the key genes involved in ALA 
biosynthesis
5-Aminolevulinic acid is a direct derivative of the tri-
carboxylic acid (TCA) cycle in the C5 pathway of C. glu-
tamicum, which was predicted by analysis of the KEGG 
database or in previous studies [15]. However, there is 
no biochemical evidence, to our knowledge, that dem-
onstrates the role of any component of the pathway. 
Three C. glutamicum genes, gltX (NP_600515.1), hemA 
(NP_599664.2), and hemL (NP_599684.1) were pre-
dicted to encode the enzymes involved in ALA biosyn-
thesis. However, the predicted amino acid sequences of 
these genes are only 31.53, 25.32, and 47.05  % identical 
to their respective cognate counterparts in E. coil, indi-
cating they need functional verification. C. glutamicum 
gltX gene was predicted to encode a glutamyl-tRNA syn-
thetase (GluRS). Conserved Domain Search showed that 
the conserved HIGH and KMSKS motifs also existed in 
the catalytic domain of C. glutamicum GluRS (Additional 
file  1: Figure S1). GluRS from C. glutamicum probably 
Fig. 1 The ALA biosynthesis pathway in C. glutamicum. The enzymes encoded by the corresponding genes are: gdh glutamate dehydrogenase; gltX 
glutamyl-tRNA synthetase; hemA glutamyl-tRNA reductase; hemL glutamate-1-semialdehyde aminotransferase; hemB 5-aminolevulinic acid dehy-
dratase. Glu glutamate; GlntRNA Glutamyl-tRNA; GSA glutamate 1-semialdehyde aminotransferase; ALA 5-aminolevulinic acid; PBG porphobilinogen
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belonged to the Class I synthetase that aminoacylates the 
3′ hydroxyl group of the cognate tRNA [16]. Glutamyl-
tRNA reductase (HemA) was predicted to be encoded by 
hemA. The reactive sulfhydryl group (Cys-50) of E. coli 
HemA requires Mg2+ to attack the α-carbonyl group of 
glutamyl-tRNA [17], and Cys-51 of C. glutamicum HemA 
is presumably similar to Cys-50 of the active site of E. coli 
HemA. Gly-197, Arg-222, Asp-285, and Pro-289 are con-
served within the NADPH binding domain and may bind 
NADPH. The predicated HemL sequence contains a pyri-
doxal 5′-phosphate binding domain, which may partici-
pate in amino acid transfer [18]. These features suggest a 
functional relationship to their E. coli counterparts.
To verify these assumptions, the three genes from C. 
glutamicum were subcloned into pUC19 (designated 
pGX, pHA, and pHL, respectively) and tested for com-
plementation of the respective E. coli mutants. The E. 
coli mutants JP1449, SASX41B, and GE1377 harboring 
a defective gltX, hemA, or hemL mutant, respectively, 
were unable to grow in minimal medium containing glu-
cose but grew on solid medium when transformed with 
the plasmids encoding the cognate C. glutamicum genes. 
Further, the recombinant strains cultivated in LB medium 
(Fig.  2a–c) grew to higher optical densities, measured 
at 600 nm (OD600), than the controls, verifying the ana-
plerotic functions of these three genes. Moreover, add-
ing ALA to cultures of the control strains increased cell 
growth to the levels of the recombinants, suggesting that 
ALA is a key intermediate that supports the growth of the 
mutants. To further characterize these genes, pGX, pHA, 
and pHL were used to transform wild-type E. coli DH5α 
to generate the E. coli strains PDGX, PDHA, and PDHL, 
which were cultivated in modified minimal medium con-
taining 20 g/L glucose, and analyzed for ALA production. 
Although OD600 values of PDGX, PDHA, and PDHL 
were lower than that of wild-type E. coli DH5α, ALA 
production by each strain was higher than that of each 
control (Fig. 2d). These results suggest that these putative 
gltX, hemA, and hemL genes encode glutamyl-tRNA syn-
thetase, glutamyl-tRNA reductase, and glutamate-1-sem-
ialdehyde aminotransferase, respectively.
The shuttle vector pECXK99E was used to overexpress 
C. glutamicum gltX, hemA, and hemL (PEGX, PEHA, 
and PEHL, respectively) in their native host. Only PEHA 
produced increased levels of ALA (Table  1). These data 
indicate that the conversion of glutamyl-tRNA to glu-
tamate-1-semialdehyde catalyzed by HemA is likely a 
rate-limiting step. Coexpression of hemL and hemA sig-
nificantly improved ALA production, which was not 
increased by further overexpression of gltX, suggesting 
that a complex mechanism regulates the activity of the 
heme biosynthetic pathway in C. glutamicum (Table 1).
Engineering C. glutamicum to enhance ALA biosynthesis
Overexpression of endogenous hemA and hemL in C. glu-
tamicum improved ALA production as well as that of its 
precursor, glutamate (Table  1), suggesting the potential 
use of C. glutamicum to produce ALA. To improve ALA 
production further, we employed genes required for its 
synthesis from other organisms (Table 2). We generated 
recombinant C. glutamicum strains designated CEAL, 
SCAL, SEAL, PSEC, and PSEE that coexpressed hemA 
with hemL and gltX from different organisms (Table  2). 
All five strains produced ALA, and the yield of SEAL was 
the highest (425  mg/L). Further, the acetate and lactate 
concentrations were low and will benefit ALA produc-
tion by C. glutamicum (Table  2). The cells and media 
turned red after approximately 8 h, indicating the forma-
tion of specific intermediates (data not shown). Analysis 
of downstream metabolites revealed the accumulation of 
porphobilinogen (PBG) and heme. The relative increases 
in the concentrations of ALA corresponded to those of 
PBG and heme, except that strains PSEC and PSEE pro-
duced PBG and heme but not ALA (Table 2). The expres-
sion of gltX in E. coli increases the expression of hemB 
(encoding 5-aminolevulinic acid dehydratase, ALAD), 
which may contribute to the synthesis of more porphy-
rin derivatives or heme [12]. However, the mechanism 
in C. glutamicum is not clear. Taken together, the data 
reveal that the activity of the Salmonella arizona mutant 
hemAM was active in C. glutamicum and that its coex-
pression with hemL greatly increased ALA accumula-
tion. Since ALA, as the precursor of heme biosynthetic 
pathway, accumulated in the engineered strain, the accu-
mulation of downstream metabolites may also increase. 
As aforementioned, the heme biosynthetic pathway was 
complicatedly regulated and was hard to be regulated. In 
order to improve ALA production, some useful strategies 
should be explored and applied.
Transcriptional analysis to identify key factors that affect 
ALA synthesis
SEAL cells and the culture medium were red, indicating 
the presence of porphyrins and heme, which may affect 
metabolism. It is hypothesized therefore that specific sets 
of genes were differentially regulated in the SEAL strain 
to restore metabolic homeostasis. To optimize culture 
conditions to increase ALA synthesis, we compared the 
gene expression levels of the SEAL cells with those of the 
control strain PECX. Total RNA was isolated when the 
cultivation medium turned red (after approximately 8 h). 
Among the nearly 3000 genes analyzed, most were down-
regulated and were identified as those involved in glucose 
transport, glycolysis, respiratory chain, or ATP synthesis 
(Additional file 1: Table S2). Specifically, the levels of ldh 
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and ackA mRNAs required for the synthesis of lactate 
and acetate, respectively, were down-regulated. Consist-
ent with these data, the SEAL strain exhibited reduced 
glycolytic activity indicated by slower acidification of the 
medium, which correlated with delayed consumption 
of glucose and decreased secretion of lactate and acetate 
Fig. 2 The complementation and ALA accumulation experiments in recombinant E. coli. a The ALA auxotrophic E. coli JP1449 containing pGX. b 
The ALA auxotrophic E. coli SASX41B containing pHA. c The ALA auxotrophic E. coli GE1377containing pHL. d The ALA accumulation in recombinant 
E. coli DH5α expressing gltX, hemA and hemL from C. glutamicum. Complementation experiments using the ALA auxotrophic strains were grown in 
LB medium supplemented with 50 μg/mL ALA (ALA+) or without ALA (ALA−). The wild type E. coli DH5α was respectively transformed with pUC19, 
pGX, pHA and pHL, generating the strain PD19, PDGX, PDHA and PDHL. Samples were taken and measured at 24 h with an interval of 4 h. The 
results were the average of three individual experiments
Table 1 ALA accumulation in recombinant C. glutamicum expressing endogenous gltX, hemA and hemL
Samples were taken and measured until 65 h and cultivation was performed at 180 rpm
40 g/L glucose was added initially















PECX – 18.84 ± 0.76 1.9 ± 0.14 25.44 ± 1.56 1.26 ± 0.26 0.12 ± 0.05
PEGX gltX 18.62 ± 0.98 1.85 ± 0.17 20.88 ± 1.34 1.27 ± 0.25 0.14 ± 0.04
PEHA hemA 19.11 ± 1.56 1.95 ± 0.15 56.89 ± 9.21 3.16 ± 0.23 0.56 ± 0.12
PEHL hemL 18.24 ± 0.87 2.05 ± 0.24 24.93 ± 2.53 1.21 ± 0.41 0.13 ± 0.08
CGAL hemA, hemL 17.63 ± 0.46 3.55 ± 0.49 79.84 ± 6.56 9.46 ± 0.54 0.82 ± 0.28
PALX hemA, hemL, gltX 17.86 ± 0.64 2.75 ± 0.31 64.55 ± 3.61 11.12 ± 0.32 1.05 ± 0.23
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(Table 2). Moreover, the down-regulation of the transcrip-
tion of genes hemH for heme synthesis, sufC and sufD 
for Fe-S cluster synthesis which are also involved in Fe2+ 
transporters, combined with the up-regulation of the tran-
scription of genes involved in oxidative stress and protein 
repair may represent strategies employed by cells to avoid 
toxicity caused by excess concentrations of heme and Fe2+. 
Down-regulated electron flow through the electron trans-
port chain, which is possibly associated with the reduced 
synthesis of heme and the Fe-S cluster, suggests that a high 
respiratory rate may adversely affect cell metabolism.
The transcriptional data suggest the likelihood that the 
potentially toxic mechanism of iron is connected with 
the high level of dissolved oxygen (DO). To address this 
question, we determined Fe2+ concentrations and DO 
levels and found that ALA production increased in pro-
portion to the decrease in the concentration of Fe2+, and 
decreased DO levels were associated with increased ALA 
production (Table  3). When we reduced the rotation of 
culture flasks to 120 rpm and reduced the concentration 
of FeSO4·7H2O to 0.01 mg/L, ALA production increased 
to 830 mg/L (Table 3), indicating that low DO and Fe2+ 
levels increased ALA production. However, when the 
culture flasks were rotated at 80  rpm, ALA production 
decreased, suggesting that the level of DO that enhanced 
ALA production must be sufficiently high to support cell 
growth. Therefore, in the following experiments, we used 
0.01 mg/L FeSO4·7H2O and rotated the culture flasks at 
120 rpm, which were optimal for producing ALA.
Inhibition of ALA downstream pathway using different 
inhibitors
Levulinic acid (LA) is a competitive inhibitor of the 
downstream metabolic pathway of ALA and is used to 
enhance ALA production [19]. For the first time to our 
knowledge, we used the other inhibitors such as maleic 
acid (MA), phthalic acid (PA), and 2-nitrobenzoic acid 
(NA) for this purpose. These inhibitors did not influ-
ence growth but did affect the accumulation of ALA 
and PBG (Fig. 3). Addition of LA, MA and PA improved 
Table 2 Engineering the ALA production in C. glutamicum using the gltX, hemA and hemL from different sources
Fermentations were performed at 180 rpm for 144 h, and the initial glucose concentration was 40 g/L
Results are the means ± standard deviations in three individual experiments
C. glutamicum 
strains
Expressed genes Cell biomass (OD600) ALA (mg/L) Lactate (g/L) Acetate (g/L) PBG (mg/L) Heme (mg/L)
PECX – 18.84 ± 0.76 25.44 ± 1.56 7.45 ± 0.46 32.41 ± 1.27 1.26 ± 0.26 0.12 ± 0.05
CEAL hemA (C. glutamicum) 
and hemL (E. coli)
18.07 ± 0.84 128.13 ± 8.94 4.25 ± 0.19 26.24 ± 2.44 21.34 ± 2.47 1.54 ± 0.28
SCAL hemAM (S. arizona) 
and hemL (C. glu-
tamicum)
17.75 ± 0.72 83.47 ± 7.33 0.19 ± 0.07 4.23 ± 0.59 11.26 ± 1.24 0.98 ± 0.18
SEAL hemAM (S. arizona) 
and hemL (E. coli)
18.33 ± 0.88 425.11 ± 15.69 0.04 ± 0.008 0.28 ± 0.03 97.87 ± 4.02 3.18 ± 0.54
PSEC hemAM (S. arizona), 
hemL (E. coli) and 
gltX (C. glutamicum)
16.81 ± 0.74 251.36 ± 10.11 0.17 ± 0.03 1.45 ± 0.12 117.92 ± 2.49 4.15 ± 0.75
PSEE hemAM (S. arizona), 
hemL (E. coli) and 
gltX (E. coli)
16.45 ± 0.78 276.21 ± 9.26 0.14 ± 0.05 1.12 ± 0.34 121.38 ± 2.53 4.22 ± 0.62
Table 3 ALA production in C. glutamicum SEAL containing various concentrations of Fe2+ at 180, 120 and 80 rpm
The concentration of FeSO4·7H2O (mg/L) ALA accumulation (mg/L)
180 rpm 120 rpm 80 rpm
10 528.2 ± 17.88 648.2 ± 16.25 364.4 ± 10.32
0.2 573.1 ± 16.34 652.1 ± 17.27 382.3 ± 13.45
0.1 612.4 ± 18.32 702.4 ± 18.49 402.5 ± 14.28
0.05 664.5 ± 19.48 738.3 ± 19.24 446.2 ± 13.89
0.01 678.3 ± 15.27 830.2 ± 21.24 482.6 ± 14.12
0 548.7 ± 14.58 692.7 ± 18.44 418.6 ± 16.02
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ALA production with the decrease of PBG accumula-
tion. However, NA did not significantly increase the 
production of ALA (data not shown). ALA production 
gradually increased when cultures were treated with con-
centrations of LA from 2.5 to 15  mM. ALA production 
was significantly decreased in the presence of 30  mM 
LA. Further, PBG production decreased in the presence 
of 2.5–30  mM LA. In contrast, low concentrations of 
MA and PA increased ALA production, which reached 
1289 and 1507 mg/L in the presence of 0.3 mM MA and 
0.1 mM of PA, respectively. Compared with the control, 
the PBG accumulation was also decreased, and exhibited 
different behaviors in compare with the presence of LA. 
These results suggest that the inhibition of downstream 
metabolic pathway of ALA affected cell metabolism and 
that this strategy increases ALA production.
Molecular genetic modifications that down‑regulate ALAD 
activity
Because inhibition of the downstream heme biosynthesis 
increased the production of ALA, and hemB (encoding 
ALAD) is required for viability, we added a degradation 
tag into the C-terminus of ALAD to increase its rate of 
degradation. The predicted amino acid sequence of C. 
glutamicum hemB (NP_599678.1) showed 46.9  % iden-
tity to its E. coli counterpart; however, the function of the 
protein encoded by C. glutamicum hemB is unknown. 
Corynebacterial SsrA tags vary in their three C-terminal 
amino acid residues and are designated ASV (AAEK-
SQRDYAASV) and AAV (AAEKSQRDYAAAV) [20]. The 
ASV tag was successfully integrated into the C-terminus 
of ALAD, but the AAV tag was failed probably due to its 
strong degradation. The plasmids pSEAL that expressed 
Fig. 3 Effects on the growth, ALA and PBG accumulation in C. glutamicum SEAL with addition of LA, MA and PA. 40 g/L glucose was added initially 
as the sole carbon source. The results are the average of three individual experiments
Page 7 of 10Yu et al. Microb Cell Fact  (2015) 14:183 
hemAM (S. arizona) and hemL (E. coli) were used to 
transform C. glutamicum that expressed ALAD with the 
C-terminal ASV tag (SEAL1). Cells that expressed SEAL1 
produced increased concentrations of ALA (1.79  g/L), 
and the concentrations of PBG in the medium were 
reduced (Fig.  4), suggesting that the predicated hemB 
gene encodes ALAD and that the degradation of ALAD 
increased ALA production.
Discussion
In the present study, we determined the functions of key 
C. glutamicum genes predicted to encode enzymes that 
mediate heme biosynthesis. Previous studies determined 
that HemA is a major control point for ALA biosynthe-
sis [12]. However, our results indicate that the relative 
activity of HemA produced by C. glutamicum is not high. 
The HemA activity of S. typhimurium is high; however, 
the enzyme is not stable in the presence of heme [21, 22]. 
Therefore, the stability of HemA was increased by insert-
ing two Lys residues (AAGAAG) between Thr-2 and 
Leu-3 at its N-terminus [21]. We show here that expres-
sion of HemAM from S. arizona with E. coli HemL by the 
recombinant strain designated SEAL produced the high-
est level of ALA, which indicates that these enzymes syn-
ergize, likely because of the formation of a tight complex. 
However, the glutamate was also detected in the culture 
medium.
Several lines of evidence indicate that heme plays a 
major role in the regulation of tetrapyrrole biosynthesis. 
For example, in the presence of an excess of intracellu-
lar heme, the activity of GluRS and the level of HemA are 
down-regulated and decrease the production of ALA [5]. 
Moreover, excess heme is toxic and perturbs the central 
metabolism of S. aureus [5]. However, we conclude that 
the low rates of growth, glucose consumption, and ALA 
synthesis may be explained by the intracellular accumu-
lation of inhibitory concentrations of porphyrins and 
heme.
Downstream products such as protoporphyrin IX 
are potentially toxic in the presence of oxygen, leading 
to the generation of reactive oxygen species [23]. Fur-
ther, the addition of iron drives ALA for porphyrins and 
heme production and causes the cultures to become red 
[24]. Higher iron concentrations influence cell growth 
and regulate heme synthesis [12]. Iron is an important 
cofactor involved in the formation of iron-sulphur (Fe-
S) clusters and the activity of heme, which are compo-
nents of oxygen-binding and regulatory proteins as well 
as those of the electron transport chain [25]. When the 
iron concentration is in excess, it may trigger the Fen-
ton reaction and cause oxidative stress [26]. However, 
the suf operon is specifically adapted to synthesize Fe-S 
clusters under iron-limiting conditions [27], and, accord-
ing to the transcriptome analysis of SEAL performed 
here, the synthesis of the Fe-S cluster will likely decrease 
when iron is in excess. Moreover, when the iron concen-
tration decreased, heme biosynthesis was likely reduced, 
which may relieve feedback inhibition of the expression 
of GluRS and HemA to the benefit of ALA synthesis. It 
has been demonstrated in vertebrate that the homeo-
static mechanisms that regulate iron and oxygen interact, 
and the balance between the contents of protoheme and 
iron to form active heme is critical [28]; however, their 
homeostatic concentrations in bacteria are unknown. 
It is interesting to note that low concentrations of Fe2+ 
and DO reduced the inhibitory effects of porphyrins 
and heme on ALA synthesis by C. glutamicum. Toxic-
ity caused by nonspecific redox cycling occurs between 
heme and oxygen when excess heme accumulates 
within the cell membrane [29], and the reduced rates of 
Fig. 4 The growth, ALA and PBG accumulation in C. glutamicum SEAL and SEAL1. SEAL contains the plasmid pSEAL, and SEAL1 contains the plas-
mid pSEAL and the ASV tag in the C-terminus of ALAD. 40 g/L glucose was added initially as the sole carbon source. The results are the average of 
three independent experiments
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respiration and heme biosynthesis may mitigate this tox-
icity. We hypothesize therefore that low levels of DO and 
Fe2+ may compensate for the excess iron available to form 
Fe-S clusters and to synthesize heme. Such a mechanism 
may adjust to down-regulate heme synthesis and electron 
transport under these conditions. The data presented are 
consistent with this hypothesis, because they indicate 
that reducing the levels of stressors and heme represents 
an efficient strategy to increase ALA production.
A hemB mutant of E. coli does not produce higher 
levels of ALA compared with wild-type [30], while 
d-glucose and d-xylose, which were used to inhibit the 
expression of ALAD, are usually metabolized [11]. There-
fore, only LA is typically used to increase ALA produc-
tion by R. sphaeroides [19, 31, 32], Chlorella vulgaris [33], 
and E. coli [34]. For example, 15  mmol/L LA inhibits 
ALAD activity by 60  % at pH 6.5 [19]. Studies of com-
pounds with different inhibitory activities reveal that 
MA and PA increased ALA production and decreased 
the production of PBG [35]. These inhibitors interact at 
distinct steps of the reaction mechanism [36], and differ-
ent classes of inhibitors exhibit significant differences in 
influencing the kinetics of the enzyme reactions that pro-
duce ALA [35]. PA may serve as a more desirable ALAD 
inhibitor, because PA is relatively inexpensive and is a 
highly efficient inhibitor.
In E. coli, protein degradation occurs, in part, through 
the tmRNA system. The C-terminal fusion of SsrA guides 
proteins to endogenous ClpXP, ClpAP, or FtsH proteases 
for rapid degradation. Variants of the E. coli SsrA tag are 
used to modify the degradation of proteins [37]. Moreo-
ver, ssrA is highly conserved, and a homologue is anno-
tated in the C. glutamicum genome [38]. The SsrA tag is 
used to monitor dynamic gene expression patterns in C. 
glutamicum [20]. Here, the addition of the SsrA tag sig-
nificantly decreased the production of PBG and increased 
ALA production in the absence of other inhibitors, indi-
cating that ALAD is a key regulatory point in the heme 
biosynthetic pathway and that genetic modification of 
ALAD will be useful for improving ALA production.
Conclusion
In summary, we identified several key genes involved 
in heme biosynthesis and demonstrated their function 
in complementation and overexpression experiments. 
Recombinant C. glutamicum strains that produce ALA 
were constructed by expressing hemA and hemL from 
different organisms. Using a strategy that included tran-
scriptome analysis and genomic modifications, we engi-
neered C. glutamicum (strain SEAL1) to produce 1.79 g/L 
of ALA in a small-scale flask culture. ALA synthesis will 
likely be improved by further optimizing culture condi-
tions using a rigorously controlled fermenter.
Methods
Strains, primers and plasmids
All strains, plasmids, and oligonucleotides used in this 
study are summarized in the additional files (see Addi-
tional file  1: Tables S3 and Table S4). The gltX, hemA, 
and hemL genes were amplified from the wild-type C. 
glutamicum ATCC 13032 genome using primers gltx-
F, gltx-R and hema-F, hema-R, and heml-F, and heml-R, 
respectively. The three amplicons were ligated to pUC19, 
which was digested with SalI (Fermentas, China) accord-
ing to the method of Gibson assembly that included T5 
exonuclease (Epicentre, USA), Phusion DNA polymerase 
(New England Biolabs, USA), and Taq DNA ligase (New 
England Biolabs, USA) [39]. Moreover, gltX, hemA, and 
hemL were cloned from the genome of C. glutamicum 
ATCC 13032 using the primers cggltx-F, cggltx-R and 
cghema-F, cgdhema-R, and cgdheml-F, cgheml-R. To 
enhance the stability of HemA, hemA was cloned from 
the S. arizona genome, which encodes the same predicted 
HemA amino acid sequence of S. typhimurium. For this 
purpose, the primers with mutations (sthemAM-F and 
sthemAM-R) were used to insert two codons (AAGAAG) 
encoding Lys between Thr-2 and Leu-3 at the N-termi-
nus [22]. One hemL gene was amplified using the prim-
ers echeml-F and echeml-R designed according to the 
sequence of the wild-type E. coli MG1655 genome, and 
hemL was cloned using primers cgheml-F and cgheml-R 
designed according to the sequence of the C. glutami-
cum ATCC 13032 genome. These amplicons contained 
30-bp overlaps and were ligated individually or together 
into pECXK99E that was cleaved with KpnI (Fermen-
tas, China) using the Gibson assembly method. The gltX 
genes were cloned from the genomes of E. coli MG1655 
and C. glutamicum ATCC 13032 using the primers 
mgltx-F, mgltx-R and cgltx-F, cgltx-R and then ligated 
into pSEAL digested with PstI using Gibson assembly. 
E. coli DH5α served as the host for molecular cloning 
and construction of plasmids. The inducible suicide vec-
tor pKJL, which was constructed from pK18mobsacB, 
was used to add ASV and AAV tags to the C-terminus 
of ALAD encoded by the C. glutamicum ATCC 13032 
genome [40]. The sequences of the plasmids were verified 
by the BioSune Company (Shanghai, China). Transforma-
tion of ALA auxotrophs and E. coli DH5α was achieved 
using the CaCl2 procedure, whereas C. glutamicum was 
electrophoretically transformed [41]. C. glutamicum 
strain ATCC 13032 was used as parental strain for ALA 
production.
Media and culture conditions
LB medium (10  g/L tryptone, 5  g/L yeast extract, and 
10  g/L NaCl, pH 7.2) and BHIS medium (2.5  g/L beef 
extract, 5  g/L tryptone, 5  g/L NaCl, 18.5  g/L brain 
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heart infusion, and 91  g/L sorbitol) were for molecu-
lar genetic procedures. Kanamycin (50  μg/mL) and 
ampicillin (100  μg/mL) were added as selective agents 
as required. E. coli was cultured using modified mini-
mal medium [12] (16  g/L (NH4)2SO4, 3  g/L KH2PO4, 
16  g/L Na2HPO4·12H2O, 1  g/L MgSO4·7H2O, 0.01  g/L 
MnSO4·7H2O, 2  g/L yeast extract, and 20  g/L glucose. 
C. glutamicum was cultured using a modified minimal 
medium (CGXII) containing glucose as the sole carbon 
source. CGXII contains (per liter) 20  g of (NH4)2SO4, 
5  g of urea, 1  g of KH2PO4, 1  g of K2HPO4, 0.25  g of 
MgSO4·7H2O, 42 g of MOPS (3-morpholinopropanesul-
fonic acid), 10 mg of CaCl2, 10 mg of FeSO4·7H2O, 10 mg 
of MnSO4·H2O, 1  mg of ZnSO4·7H2O, 0.2  mg CuSO4, 
0.02 mg NiCl2·6H2O, 0.02 g citrate sodium, and pH 7.0. 
To induce the expression of plasmid genes, isopropyl-β-
d-thiogalactopyranoside was added to the cultures at a 
final concentration of 0.25 mM.
ALA was produced at 30 °C in 300 mL using ordinary 
flasks containing 50 mL modified CGXII. Starter cultures 
contained 5  ml LB with glucose were routinely inocu-
lated with a single colony from a freshly streaked agar 
plate, the culture flasks were rotated at 180 rpm for 14 h 
at 30  °C, and the cells were harvested, and washed with 
sterile 0.9 % NaCl and CGXII containing 5.0 μg/L biotin. 
The resuspended cells were used to inoculate a second 
culture containing 5.0 μg/L biotin, and the initial OD600 
was adjusted to approximately 0.5. After approximately 
12  h incubation at 30  °C at 170  rpm, the cells in the 
exponential growth phase were harvested and washed 
sequentially with sterile 0.9 % NaCl solution and CGXII 
containing 1.0 μg/L biotin and inoculated into the main 
culture that was adjusted to approximately 0.8 OD600. 
The initial pH was adjusted to 7.0 (optimum), then main-
tained at approximately pH 6.5 using 4  M NaOH. The 
inhibitors LA, MA, PA, and NA were added at approxi-
mately 8 h.
Substrate, product, and RNA‑Seq analysis
For quantification of extracellular glucose, glutamate, and 
ALA, aliquots of the culture were withdrawn and the cells 
were removed by centrifugation (12,000×g, 10  min). The 
OD600 was determined using a spectrophotometer (Shi-
madzu, Japan), and the supernatant was analyzed for glu-
cose and glutamate using a SBA-40C biosensor (developed 
by Biology Institute of Shandong Academy of Sciences) 
equipped with glucose and glutamate oxidase immobi-
lized on membranes. To determine the concentrations of 
organic acids, high-performance liquid chromatography 
(HPLC) was used (Shimadzu). The supernatant was filtered 
through a 0.22-mm syringe filter. The HPLC system was 
equipped with a HPX-87H column (300  mm ×  7.8  mm, 
Bio-Rad, USA) and a differential refractive index (RI) 
detector (Shimadzu RID-10A). The mobile phase (0.5 mM 
H2SO4) was delivered at 0.6 mL/min at 65 °C. To measure 
ALA and PBG concentrations, we used modified Ehrlich’s 
reagent and measured absorbance at 554  nm [42]. For 
heme measurements, a fluorescence assay was used [43]. 
RNA-Seq was performed according to the Illumina mRNA 
Sequencing Sample Preparation Guide (Illumina), and 
sequenced using an Illumina HiSeq sequencer (Illumina) at 
BGI Tech Company (Shenzhen, China). The raw sequenc-
ing data were analyzed using the software included with 
the system (Illumina).
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